These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 35431924)

  • 1. NUSAP1 Could be a Potential Target for Preventing NAFLD Progression to Liver Cancer.
    Zeng T; Chen G; Qiao X; Chen H; Sun L; Ma Q; Li N; Wang J; Dai C; Xu F
    Front Pharmacol; 2022; 13():823140. PubMed ID: 35431924
    [No Abstract]   [Full Text] [Related]  

  • 2. Microarray-based Detection of Critical Overexpressed Genes in the Progression of Hepatic Fibrosis in Non-alcoholic Fatty Liver Disease: A Protein-protein Interaction Network Analysis.
    Mahmoudi A; Butler AE; De Vincentis A; Jamialahmadi T; Sahebkar A
    Curr Med Chem; 2024; 31(23):3631-3652. PubMed ID: 37194229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of common signature genes and pathways underlying the pathogenesis association between nonalcoholic fatty liver disease and heart failure.
    Li G; Lu Z; Chen Z
    Front Immunol; 2024; 15():1424308. PubMed ID: 39351239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M
    Gene; 2020 Jun; 742():144549. PubMed ID: 32184169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of key pathways and genes in nonalcoholic fatty liver disease using bioinformatics analysis.
    Liu J; Lin B; Chen Z; Deng M; Wang Y; Wang J; Chen L; Zhang Z; Xiao X; Chen C; Song Y
    Arch Med Sci; 2020; 16(2):374-385. PubMed ID: 32190149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unveiling NUSAP1 as a common gene signature linking chronic HBV infection and HBV-related HCC.
    Meng J; Yang Z; Jiang X; Zou J
    Discov Oncol; 2024 Mar; 15(1):61. PubMed ID: 38441732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of differentially expressed genes and immune cell infiltration in the progression of nonalcoholic steatohepatitis (NASH) to hepatocellular carcinoma (HCC): a new exploration based on bioinformatics analysis.
    Liu Y; Yu X; Wang Y; Wu J; Feng B; Li M
    Nucleosides Nucleotides Nucleic Acids; 2024; 43(12):1415-1430. PubMed ID: 38319987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shared Genes and Molecular Mechanisms between Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma Established by WGCNA Analysis.
    He J; Zhang X; Chen X; Xu Z; Chen X; Xu J
    Glob Med Genet; 2023 Sep; 10(3):144-158. PubMed ID: 37501756
    [No Abstract]   [Full Text] [Related]  

  • 9. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of Autophagy-Related Genes in the Progression from Non-Alcoholic Fatty Liver to Non-Alcoholic Steatohepatitis.
    Ma M; Xie W; Li X
    Int J Gen Med; 2021; 14():3163-3176. PubMed ID: 34262330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular basis of the associations between non-alcoholic fatty liver disease and colorectal cancer.
    Qiu T; Hu W; Rao Z; Fang T
    Front Genet; 2022; 13():1007337. PubMed ID: 36568397
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods.
    Li Z; Lin Y; Cheng B; Zhang Q; Cai Y
    Front Genet; 2021; 12():571231. PubMed ID: 33767726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of common signature genes and pathways underlying the pathogenesis association between nonalcoholic fatty liver disease and atherosclerosis.
    Mo S; Wang Y; Yuan X; Wu W; Zhao H; Wei H; Qin H; Jiang H; Qin S
    Front Cardiovasc Med; 2023; 10():1142296. PubMed ID: 37063958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyzing Roles of NUSAP1 From Clinical, Molecular Mechanism and Immune Perspectives in Hepatocellular Carcinoma.
    Zhu W; Xu J; Chen Z; Jiang J
    Front Genet; 2021; 12():689159. PubMed ID: 34354737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LUM is the hub gene of advanced fibrosis in nonalcoholic fatty liver disease patients.
    Chang Y; He J; Xiang X; Li H
    Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101435. PubMed ID: 32386798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of the Key Genes for the Progression of Liver Cirrhosis to Hepatocellular Carcinoma Based on Bioinformatics.
    Chen Y; Qian H; He X; Zhang J; Xue S; Wu Y; Chen J; Wu X; Zhang S
    J Oncol; 2022; 2022():2515513. PubMed ID: 36199789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of hub genes and key pathways of dietary advanced glycation end products‑induced non‑alcoholic fatty liver disease by bioinformatics analysis and animal experiments.
    Wang J; Liu H; Xie G; Cai W; Xu J
    Mol Med Rep; 2020 Feb; 21(2):685-694. PubMed ID: 31974594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of genes and key pathways underlying the pathophysiological association between nonalcoholic fatty liver disease and atrial fibrillation.
    Chu Y; Yu F; Wu Y; Yang J; Shi J; Ye T; Han D; Wang X
    BMC Med Genomics; 2022 Jul; 15(1):150. PubMed ID: 35790963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.